CURG holdings
As of , CURG (VanEck Genomics and Healthcare Innovators UCITS ETF Accum A USD, ISIN IE000B9PQW54) has 49 holdings on our record, together 100.0% of the fund; the ten largest make up 60.3%. VanEck reports 50 positions in all. Weights are shares of the whole fund.
Largest holdings
| Rank# | Holding | Weight as a percentage of the fund |
|---|---|---|
| 1 | ModernaMRNA | 9.12% |
| 2 | Vertex Pharmaceuticals | 7.36% |
| 3 | NateraNTRA | 6.89% |
| 4 | Regeneron PharmaceuticalsREGN | 6.89% |
| 5 | Veeva SystemsVEEV | 6.53% |
| 6 | IlluminaILMN | 6.13% |
| 7 | DexComDXCM | 5.19% |
| 8 | Guardant HealthGH | 4.52% |
| 9 | Alnylam PharmaceuticalsALNY | 3.95% |
| 10 | BioNTechBNTX | 3.70% |
Source: VanEck, holdings as published, as of
More of the portfolio
The fund publishes 50 holdings; the ten largest make up 60.3% of it. The fund's portfolio is also split by currency.
Create a free account to see the full holdings list and the currency, maturity and credit-quality breakdowns
Sign-up takes an email address. There is no card to enter and nothing to pay.
Where it invests
The whole portfolio by sector, country and type of asset, every line, as a share of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed.
By sector
- Health Care97.4%
- Consumer Staples2.6%
By country
- United States85.4%
- China4.5%
- Germany3.7%
- Australia1.8%
- Switzerland1.3%
- Japan1.2%
- Sweden1.1%
- United Kingdom0.6%
- Netherlands0.5%
More:CURG: key facts, returns and chargesCompare what it holds with another fundHoldings overlapHow overlap is measured
Holdings and weights are as published by VanEck on 30/09/2026 and change as the fund trades.